SD
Sanjay Dhir
About Sanjay Dhir
Data last updated:
Sanjay Dhir is a Director at Preet Remedies Limited (since 2009), Whole-Time Director at Zenlabs Ethica Limited (since 2016) and Director at Quixotic Pharma Private Limited (since 2018), and holds 1 more current directorship. The companies operate in Pharma and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹152 Cr; the largest is Preet Remedies Limited at ₹62.83 Cr (FY 2025). Earlier, Sanjay Dhir was a Director at Zen Labs India Private Limited (from 2009) and Additional Director at Hexford Laboratories Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 May 2009 | 2005 | ₹62.83 Cr (FY 2025) | Active | |
| Whole-Time Director | 11 Aug 2016 | 1993 | ₹51.47 Cr (FY 2025) | Active | |
| Director | 01 Feb 2018 | 2002 | ₹27.58 Cr (FY 2025) | Active | |
| Managing Director | 15 Jan 2015 | 2007 | ₹10.36 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Jan 2009 | 2009 | Strike Off | ||
| Additional Director | 21 Nov 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Dhir
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhishek Rana | 10480804 | Preet Remedies Limited | Director |
| Hitesh Popatlal Oswal | 06715966 | Preet Remedies Limited , Quixotic Pharma Private Limited | Director |
| Prasanna Kumar Rout | 10432013 | Preet Remedies Limited | Director |
| Sanjeev Kumar | 01154896 | Preet Remedies Limited , Zenlabs Ethica Limited and 2 more | Managing Director |
| Vijendra Kumar Gupta | 10944835 | Preet Remedies Limited | Director |
| Anurag Malhotra | 07552713 | Zenlabs Ethica Limited | Director |
| Himjyoti | 02398927 | Zenlabs Ethica Limited | Director |
| Kuldeep Singh | 08454422 | Zenlabs Ethica Limited | Director |
| Nikunj Goel | Zenlabs Ethica Limited | Company Secretary | |
| Sanjeev Singal | Zenlabs Ethica Limited | Ceo | |
| Sudhakar | 10278181 | Quixotic Pharma Private Limited | Director |
| Ashok Kumar Mishra | 10982749 | Quixotic Pharma Private Limited | Director |
| Rajesh Biswanath Shrivastava | 00155198 | Quixotic Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Dhir
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Dhir
Sanjay Dhir currently holds 4 directorships: Preet Remedies Limited (Director, since 01 May 2009, revenue ₹62.83 Cr (FY 2025)); Zenlabs Ethica Limited (Whole-Time Director, since 11 Aug 2016, revenue ₹51.47 Cr (FY 2025)); Quixotic Pharma Private Limited (Director, since 01 Feb 2018, revenue ₹27.58 Cr (FY 2025)); Oasis Pharma And Phytomolecules Private Limited (Managing Director, since 15 Jan 2015, revenue ₹10.36 Cr (FY 2025)).
Sanjay Dhir was first appointed on 27 Jan 2009 as Director at Zen Labs India Private Limited. The most recent appointment on record is 01 Feb 2018 at Quixotic Pharma Private Limited.
The 4 current companies of Sanjay Dhir that report revenue have a combined latest revenue of ₹152 Cr: Preet Remedies Limited ₹62.83 Cr (FY 2025); Zenlabs Ethica Limited ₹51.47 Cr (FY 2025); Quixotic Pharma Private Limited ₹27.58 Cr (FY 2025); Oasis Pharma And Phytomolecules Private Limited ₹10.36 Cr (FY 2025).
Sanjay Dhir held 2 earlier board appointments: Zen Labs India Private Limited (Director, from 27 Jan 2009); Hexford Laboratories Private Limited (Additional Director, from 21 Nov 2009).
The current boards of Sanjay Dhir's companies include Abhishek Rana (Preet Remedies Limited), Hitesh Popatlal Oswal (Preet Remedies Limited), Prasanna Kumar Rout (Preet Remedies Limited), Sanjeev Kumar (Preet Remedies Limited), Vijendra Kumar Gupta (Preet Remedies Limited), Anurag Malhotra (Zenlabs Ethica Limited), among others.